(Q36535204)

14 August 2017

1 reference

title

Uveitis: advances in understanding of pathogenesis and treatment (English)

1 reference

14 August 2017

1 reference

Russell W Read

1

1 reference

14 August 2017

language of work or name

1 reference

1 August 2006

1 reference

Current Rheumatology Reports

14 August 2017

published in

1 reference

14 August 2017

volume

8

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

260-266

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-006-0006-6

14 August 2017

exact match

0 references

cites work

Epidemiology of uveitis. Incidence and prevalence in a small urban community

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-006-0006-6

Referral patterns of uveitis in a tertiary eye care center.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-006-0006-6

Causes of uveitis in the general practice of ophthalmology

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-006-0006-6

Uveitis in the southeastern United States.

21 January 2018

1 reference

12 December 2020

Vitamin E in the treatment of uveitis-associated macular edema

1 reference

12 December 2020

Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis

1 reference

12 December 2020

An update on current practices in the management of ocular toxoplasmosis

1 reference

12 December 2020

The natural history of uveitis

1 reference

12 December 2020

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

1 reference

12 December 2020

Changing patterns of uveitis

1 reference

12 December 2020

Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.

1 reference

12 December 2020

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept

1 reference

12 December 2020

High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis

1 reference

12 December 2020

The possible impact of uveitis in blindness: a literature survey

1 reference

12 December 2020

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 reference

12 December 2020

Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature

1 reference

12 December 2020

Somatostatin for Uveitic Cystoid Macular Edema (CME).

1 reference

12 December 2020

A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis

1 reference

12 December 2020

Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group

1 reference

12 December 2020

Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion

1 reference

12 December 2020

Uveitis in Behçet disease: an analysis of 880 patients.

1 reference

12 December 2020

Interferon as a treatment for uveitis associated with multiple sclerosis

1 reference

12 December 2020

Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease

1 reference

12 December 2020

Vogt-Koyanagi-Harada disease: clinical outcomes

1 reference

12 December 2020

Mycophenolate mofetil therapy for inflammatory eye disease

1 reference

12 December 2020

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

1 reference

12 December 2020

Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet disease

1 reference

12 December 2020

The reported demography and causes of blindness throughout the world.

1 reference

12 December 2020

Infliximab for juvenile idiopathic arthritis-associated uveitis

1 reference

12 December 2020

Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection

1 reference

12 December 2020

Repeated intravitreal triamcinolone injections in Behçet disease that is resistant to conventional therapy: one-year results

1 reference

12 December 2020

Acute endophthalmitis incidence: intravitreal triamcinolone

1 reference

12 December 2020

Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort

1 reference

12 December 2020

Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.

1 reference

12 December 2020

Infliximab in the treatment of posterior uveitis in Behçet's disease. Long term follow up in four patients

1 reference

12 December 2020

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

1 reference

12 December 2020

Retrospective case review of pediatric patients with uveitis treated with infliximab

1 reference

12 December 2020

Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study

1 reference

12 December 2020

Endogenous uveitis: an analysis of 1,417 cases

1 reference

12 December 2020

Rubella virus is associated with fuchs heterochromic iridocyclitis

1 reference

12 December 2020

Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis

1 reference

12 December 2020

Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients

1 reference

12 December 2020

10.1007/S11926-006-0006-6

Identifiers

DOI

1 reference

14 August 2017

1 reference